Retatrutide is a novel injectable peptide acting as a triple agonist of GLP-1, GIP, and glucagon receptors. Designed to target multiple metabolic pathways simultaneously, it offers a powerful approach to weight management and metabolic health. Originally developed for advanced research, Retatrutide shows promising potential in promoting significant fat loss, appetite suppression, and improved glucose regulation.
